Helix BioMedix, Inc. (HXBM)
HXBM Stock Price Chart
Explore Helix BioMedix, Inc. interactive price chart. Choose custom timeframes to analyze HXBM price movements and trends.
HXBM Company Profile
Discover essential business fundamentals and corporate details for Helix BioMedix, Inc. (HXBM) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
25 Mar 1999
Employees
8.00
Website
https://www.helixbiomedix.comCEO
Robin L. Carmichael
Description
Helix BioMedix, Inc. operates as a specialty dermatology and consumer products skin health company in the United States. It develops and commercializes bioactive peptides, including anti-infective, anti-fungal, and anti-inflammatory peptides for the treatment of skin and wound infections, as well as for the prevention of staphylococcus aureus infections. The company also out-licenses its proprietary peptides to various entities. Helix BioMedix, Inc. was founded in 1988 and is headquartered in Bothell, Washington.
HXBM Financial Timeline
Browse a chronological timeline of Helix BioMedix, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
HXBM Stock Performance
Access detailed HXBM performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.